OvaScience announces plans to price public offering of common stock

Leerink Partners is bookrunner; proceeds fund preclinical studies

By Devika Patel

Knoxville, Tenn., March 3 - OvaScience, Inc. said it will price a public offering of common stock with a 15%, 30-day greenshoe.

Leerink Partners, LLC is the bookrunning manager.

Proceeds will be used for OvaPrime preclinical studies and the anticipated 2015 international launch, to expand the Augment international launch, establish an international subsidiary and for other general corporate purposes.

Based in Cambridge, Mass., OvaScience is a fertility company focused on new treatments for infertility.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.